Leonard Lothstein
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 13
- Cancer Treatment and Pharmacology 7
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 6
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 13
- Cell death mechanisms and regulation 5
- RNA Interference and Gene Delivery 4
- Glycosylation and Glycoproteins Research 3
- Mitochondrial Function and Pathology 3
- Cell Biology top 10%
- Cancer Research top 10%
- Co-authors
- Susan Band HorwitzTrevor W. SweatmanMervyn IsraelS HsuS. RoyJerome ParnessPeter B. SchiffJames J. Manfredi
- Cited by
- OncologyToxicologyMolecular Biology
- Journals
- Anti-Cancer Drugs (3 papers)Journal of Biological Chemistry (3 papers)Molecular and Cellular Biology (3 papers)
- Partner nations
- United StatesSwitzerlandArgentina
In The Last Decade
Leonard Lothstein
37 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 82
- Oncology 890
- Toxicology 60
- Molecular Biology 978
- Cell Biology 187
- Cancer Research 164
Countries citing papers authored by Leonard Lothstein
This map shows the geographic impact of Leonard Lothstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Lothstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Lothstein more than expected).
Fields of papers citing papers by Leonard Lothstein
This network shows the impact of papers produced by Leonard Lothstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Lothstein. The network helps show where Leonard Lothstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leonard Lothstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2018 | 5 | |
| 3 | 2010 | 24 | |
| 4 | 2010 | 26 | |
| 5 | 2009 | 25 | |
| 6 | 2007 | 16 | |
| 7 | 2007 | 47 | |
| 8 | 2006 | 15 | |
| 9 | 2006 | 10 | |
| 10 | 2004 | 19 | |
| 11 | 2001 | 66 | |
| 12 | 2000 | 13 | |
| 13 | Cellular resistance against the novel hybrid anthracycline N-(2-chloroethyl)-N-nitrosoureidodaunorubicin (AD 312) is mediated by combined altered topoisomerase II and O6-methylguanine-DNA methyltransferase activities. | 1998 | 6 |
| 14 | 1998 | 20 | |
| 15 | 1994 | 5 | |
| 16 | 1990 | 20 | |
| 17 | 1990 | 115 | |
| 18 | 1988 | 80 | |
| 19 | 1985 | 88 | |
| 20 | 1980 | 34 |
About Leonard Lothstein
Leonard Lothstein is a scholar working on Toxicology, Oncology, Molecular Biology, Biophysics and Biomaterials, having authored 37 papers that have together received 1.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (7 papers), Bioactive Compounds and Antitumor Agents (6 papers), Cell death mechanisms and regulation (5 papers), RNA Interference and Gene Delivery (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Oncology (890 citations), Toxicology (60 citations), Molecular Biology (978 citations), Cell Biology (187 citations) and Cancer Research (164 citations). Leonard Lothstein has collaborated with scholars based in United States, Switzerland and Argentina. Frequent co-authors include Susan Band Horwitz, Trevor W. Sweatman, Mervyn Israel, S Hsu, S. Roy, Jerome Parness, Peter B. Schiff, James J. Manfredi, Wilfredo Mellado and R Zeheb. Their work appears in journals such as Anti-Cancer Drugs, Journal of Biological Chemistry, Molecular and Cellular Biology, Journal of Pharmacology and Experimental Therapeutics and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.